Hypoglycemic effects and biochemical mechanisms of oat products on streptozotocin-induced diabetic mice

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 16, 2011, Pages 8895-8900

  Shen, Rui Ling ^a   Cai, Feng Li ^a   Dong, Ji Lin ^a   Hu, Xin Zhong ^b  

^a ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY   (China)

^b NORTHWEST A F UNIVERSITY   (China)

Author keywords

hypoglycemic effects; hypoglycemic mechanism; oat products; type II diabetes mellitus

Indexed keywords

BIOCHEMICAL MECHANISMS; BLOOD GLUCOSE; DIABETIC MICE; FAT METABOLISM; FREE FATTY ACID; GLYCEMIA; GLYCEMIC INDEX; GLYCOSYLATED; HYPOGLYCEMIC EFFECT; HYPOGLYCEMIC MECHANISM; METFORMINS; NUCLEAR RECEPTORS; OAT PRODUCTS; ORGAN FUNCTIONS; POTENTIAL MECHANISM; SERUM PROTEINS; SUCCINATE DEHYDROGENASE; TYPE II;

CELL DEATH; ENZYME INHIBITION; FATTY ACIDS; MAMMALS; PHYSIOLOGY;

GLUCOSE;

ANTIDIABETIC AGENT; BETA GLUCAN; METFORMIN;

ANIMAL; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DIET THERAPY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OAT; PLANT SEED;

ANIMALS; AVENA SATIVA; BETA-GLUCANS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GLYCEMIC INDEX; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MICE; SEEDS;

MUS;

EID: 80051721118     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf200678q     Document Type: Article

References (27)

1. Silva, L. P.; Santorio Ciocca, M. L. Total, insoluble and soluble dietary fiber values measured by enzymatic-gravimetric method in cereal grain J. Food Compos. Anal. 2005, 18, 113-120
2. Kendall, C. W. C.; Esfahani, A.; Jenkins, D. J. A. The link between dietary fiber and human health Food Hydrocolloids 2010, 24, 42-48
3. Kuzuya, T.; Nakagawa, S.; Satoh, J.; Kanazawa, Y.; Iwamoto, Y.; Kobayashi, M.; Nanjo, K.; Sasaki, A.; Seino, Y.; Ito, C.; Shima, K.; Nonaka, K.; Kadowaki, T. Report of the committee on the classification and diagnostic criteria of diabetes mellitus Diabetol. Int. 2010, 1, 2-20
4. Alminger, M.; Eklund-Jonsson, C. Whole-grain cereal products based on a high-fiber barley or oat genotype lower post-prandial glucose and insulin responses in healthy humans Eur. J. Nutr. 2008, 47, 294-300
5. Tapola, N.; Karvonen, H.; Niskanen, L.; Mikola, M.; Sarkkinen, E. Glycemic responses of oat bran products in type II diabetic patients Nutr. Metab. Cardiovas. 2005, 15, 255-261 (Pubitemid 41190982)
6. Jiménez-Cruz, A.; Turnbull, W. H.; Bacardi-Gascón, M.; Rosales-Garay, P. A high-fiber, moderate-glycemic-index, Mexican style diet improves dyslipidemia in individuals with type 2 diabetes Nutr. Res. (N.Y.) 2004, 24, 19-27 (Pubitemid 38121535)
7. Morvarid, K.; Jean, M. O.; Hubert, V.; Francoise, B.; Caroline, F.; Pierre, W.; Gerard, S.; Salwa, W. R. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men Metabolism 2002, 51, 819-826
8. Brennan, C. S.; Cleary, L. J. The potential use of cereal (1→3, 1→4)-β- d -glucans as functional food ingredients J. Cereal Sci. 2005, 42, 1-13 (Pubitemid 40717556)
9. Jenkins, A. L.; Jenkins, D. J. A.; Zdravkovic, U.; Würsch, P.; Vuksan, V. Depression of the glycemic index by high levels of β-glucan fiber in two functional foods tested in type II diabetes Eur. J. Clin. Nutr. 2002, 56, 622-628 (Pubitemid 34822901)
10. Thondre, P. S.; Henry, C. J. K. High-molecular-weight barley β-glucan in chapattis (unleavened Indian flatbread) lowers glycemic index Nutr. Res. (N.Y.) 2009, 29, 480-486
11. Bnttilana, P.; Ornstein, K.; Minehira, K.; Schwarz, J. M.; Acheson, K.; Schneiter, P.; Burri, J.; Jéquier; Tappy, L. Mechanisms of action of β-glucan in postprandial glucose metabolism in healthy men Eur. J. Clin. Nutr. 2001, 55, 327-333 (Pubitemid 32396741)
12. American Association of Cereal Chemists. Approved Methods of the American Association of Cereal Chemists, 10 th ed.; AACC: St. Paul, MN, 2000.
13. Shen, R.; Cai, F. The effects of oat β-glucan on the hypoglycemic of type 2 diabetic mice. Bioinformatics and Biomedical Engineeering (ICBBE); 4th International Conference, 2010, doi: 10.1109/ICBBE.2010.5516500.
14. Yoshida, T.; Okuno, A.; Tanaka, J.; Takahashi, K.; Nakashima, R.; Kanda, S.; Ogawa, J.; Hagisawa, Y.; Fujiwara, T. Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type II diabetes Goto-Kakizaki rats Eur. J. Pharmacol. 2009, 623, 141-147
15. Dong, J.; Cai, F.; Shen, R.; Liu, Y. Hypoglycemic effects and inhibitory effect on intestinal disaccharidases of oat β-glucan in streptozotocin-induced diabetic mice. Food Chem. 2011, doi: 10.1016/j.foodchem. 2011.05.076.
16. Bonadonna, R. C. Alterations of glucose metabolism in type II diabetes mellitus Endocr. Metab. Dis. 2004, 5, 89-97 (Pubitemid 39012106)
17. Hikino, H.; Kobayashi, M.; Suzuki, Y.; Konno, C. Mechanism of hypoglycemic activity of aconitan A, a glycan from Aconitum carmichaeli roots J. Ethnopharmacol. 1989, 25, 295-304 (Pubitemid 19120367)
18. Masiello, P. Animal models of type II diabetes with reduced pancreatic β-cell mass Int. J. Biochem. Cell Biol. 2006, 38, 873-893 (Pubitemid 43363418)
19. Tomas, E.; Habener, J. F. Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis Trends Endocrinol. Metab. 2010, 21, 59-67
20. Dungan, K.; Buse, J. B. Glucagon-liked peptide 1-based therapies for type II diabetes: a focus on exenatide Clin. Diabetes 2005, 23, 56-62 (Pubitemid 40965046)
21. Zander, M.; Madsbad, S.; Madsen, J. L.; Holst, J. J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type II diabetes: a parallel-group study Lancet 2002, 359, 824-830 (Pubitemid 34233752)
22. Wilding, J. P. The importance of free fatty acids in the development of type II diabetes Diabet. Med. 2007, 24, 934-945 (Pubitemid 47304378)
23. Boden, G.; Shulman, G. I. Free fatty acids in obesity and type II diabetes: defining their role in the development of insulin resistance and β-cell dysfunction Eur. J. Clin. Invest. 2002, 32 (Suppl. 3) 14-23 (Pubitemid 41704996)
24. Assimacopoulos-Jeannet, F. Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type II diabetes Int. J. Obes. Metab. Disord. 2004, 28, S53-S57 (Pubitemid 40143849)
25. Zraika, S.; Dunlop, M.; Proietto, J.; Andrikopoulos, S. Effects of free fatty acids on insulin secretion in obesity Obes Rev. 2002, 3, 103-112 (Pubitemid 34827151)
26. Berger, J. P.; Akiyama, T. E.; Meinke, P. T. PPARs: therapeutic targets for metabolic disease Trends Pharmacol. Sci. 2005, 26, 244-251 (Pubitemid 40603072)
27. Bays, H.; Mandarino, L.; DeFronzo, R. A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type II diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach J. Clin. Endocrinol. Metab. 2004, 89, 463-478 (Pubitemid 38269844)